|
Volumn 480, Issue 7377, 2011, Pages S34-S35
|
Overview: Multiple lines of attack
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BORTEZOMIB;
IMMUNOGLOBULIN;
LENALIDOMIDE;
MELPHALAN;
PREDNISONE;
ANTIBODY;
BLOOD;
CANCER;
CHROMOSOME;
DISEASE TREATMENT;
DRUG;
INFECTIOUS DISEASE;
INHIBITOR;
LIFE EXPECTANCY;
MOLECULAR ANALYSIS;
PROTEIN;
RESEARCH WORK;
RISK FACTOR;
SURVIVAL;
ANEMIA;
ANTIBODY PRODUCTION;
BONE LESION;
CANCER MORTALITY;
GEOGRAPHIC DISTRIBUTION;
HUMAN;
IMMUNE SYSTEM;
KIDNEY FAILURE;
LEUKOCYTE;
MONOCLONAL IMMUNOGLOBULINEMIA;
MULTIPLE MYELOMA;
NONHODGKIN LYMPHOMA;
PLASMA CELL;
PRIORITY JOURNAL;
RARE DISEASE;
REVIEW;
RISK FACTOR;
STEM CELL TRANSPLANTATION;
HUMANS;
INDIVIDUALIZED MEDICINE;
MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE;
MULTIPLE MYELOMA;
SURVIVAL RATE;
TRANSLOCATION, GENETIC;
UNITED STATES;
|
EID: 83455186364
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/480S34a Document Type: Article |
Times cited : (4)
|
References (1)
|